AINDEX
Markets

Nutriband Inc. (NTRB)

NTRBNASDAQ-CMIndustrial Specialties

$5.59

-0.3100 (-5.25%) today

Closed, Nov 17, 4:00 PM ET

-5.25% 1D
Market cap
$70.62m
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
–
52-week range
$2.80 to $9.19
Average volume
–
Previous close
$5.90

Earnings

Next report Dec 9, 2026

Financials

QuarterOct 2025Jan 2026Apr 2026Jul 2026
Revenue$346.0k$401.0k$433.0k$438.0k
Gross profit$69.0k$89.0k$197.0k$182.0k
Operating income-$3.88m-$1.02m-$1.25m-$891.0k
Net income-$3.87m-$968.0k-$1.24m-$881.0k

Last four quarters: revenue $1.62m, margin -430.4%, free cash flow –

News

8 latest

The company

We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Sector
Health Care
Industry
Industrial Specialties
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.